Skip to main content
. 2013 Jan 3;10(2):141–147. doi: 10.7150/ijms.5125

Table 1.

Energy, macronutrient and creatine intake during the study. Values are mean ± SD.

Placebo (n = 11) GAA (n = 12) P *
Baseline Week 2 Week 4 Week 6 Baseline Week 2 Week 4 Week 6
Total energy intake (kcal/day) 3173 ± 649 3492 ± 727 3670 ± 716 3806 ± 624 3467 ± 870 3594 ± 984 3707 ± 1030 3827 ± 886 0.59
Carbohydrates (%) 62.1 ± 4.4 64.8 ± 5.6 65.5 ± 3.7 64.9 ± 4.0 63.9 ± 5.8 64.2 ± 5.2 64.4 ± 4.1 64.9 ± 4.4 0.98
Lipids (%) 23.0 ± 4.1 21.4 ± 5.0 20.9 ± 3.7 20.7 ± 2.8 23.2 ± 6.0 21.6 ± 4.2 21.0 ± 3.7 21.8 ± 3.5 0.58
Proteins (%) 14.9 ± 3.7 13.8 ± 5.0 13.6 ± 4.7 14.4 ± 4.4 12.9 ± 4.3 14.3 ± 4.5 14.6 ± 4.9 13.3 ± 5.0 0.45
Creatine (g/day) 0.39 ± 0.08 0.42 ± 0.09 0.44 ± 0.09 0.48 ± 0.08 0.39 ± 0.10 0.45 ± 0.12 0.47 ± 0.13 0.45 ± 0.10 0.78

Note * P value from two-way ANOVA with repeated measures for treatment vs. time interaction.